Showing 1,658 news articles about Hepatitis & HIV

Filters Content type: Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Pharmaceutical industry

How CDC's hep.-C testing advice is already benefiting drugmakers

Editor's pick
Medical Marketing and Media
23 May 2012
Hepatitis C symptoms & diagnosis

CDC recommends hepatitis C tests for all baby boomers

Editor's pick
Washington Post
20 May 2012
New & experimental hepatitis C treatment

Incivek Rash Reports: What HIV/Hepatitis C-Coinfected People Need to Know

Editor's pick
The Body
18 May 2012
New & experimental hepatitis C treatment

Achillion's hepatitis C drug gets FDA fast track

Editor's pick
Reuters
16 May 2012
Cancer

Four Bad Actors Cause Most Infection-Related Cancer

Editor's pick
Medscape (requires registration)
11 May 2012
New & experimental hepatitis C treatment

New Drugs Require New Terms for HCV Virologic Response

Editor's pick
Medscape (requires registration)
9 May 2012
New & experimental hepatitis C treatment

Aethlon Medical Reports Undetectable Hepatitis C Virus (HCV) in Genotype 1, Genotype 3, and Genotype 5 Patients Treated with Hemopurifier® Therapy

Editor's pick
MarketWatch (press release)
8 May 2012
Hepatitis & HIV

Liver transplants in HIV-HCV co-infection—results from a U.S. study

Editor's pick
CATIE
8 May 2012
New & experimental hepatitis C treatment

Bristol-Myers Missing Hep C Data Raises Red Flags, May Boost Gilead, Idenix

Editor's pick
The Street
8 May 2012
Hepatitis C transmission & prevention

Hepatitis C a latent legacy of baby boomers' youth

Editor's pick
Los Angeles Times
2 May 2012
Hepatitis C transmission & prevention

Scotland: Quality Indicators for Hepatitis C

Editor's pick
Health Care Improvement Scotland
30 April 2012
Pharmaceutical industry

Gilead Sciences 1Q profit down on Pharmasset costs

Editor's pick
CBS News
27 April 2012
New & experimental hepatitis C treatment

US: do not mix Merck hepatitis pill with HIV drugs

Editor's pick
Reuters
27 April 2012
New & experimental hepatitis C treatment

NICE publishes final guidance on two new drugs for chronic hepatitis C

Editor's pick
NICE press release
25 April 2012
Hepatitis & HIV

Family history ups liver cancer risk

Editor's pick
Times of India
25 April 2012
New & experimental hepatitis C treatment

Telaprevir May Cause Severe Cutaneous Eruptions

Editor's pick
Medscape (requires free registration)
24 April 2012
New & experimental hepatitis C treatment

Grading Hep C Stocks Exiting EASL - The future of hepatitis C therapy belongs to interferon-free regimens

Editor's pick
The Street
23 April 2012
New & experimental hepatitis C treatment

Achillion Announces 94 - 100% Complete EVR From Phase 2 Trial With ACH-1625 Based Regimen in Hepatitis C

Editor's pick
Achillion (press release)
23 April 2012
New & experimental hepatitis C treatment

Achillion Clarifies End of Treatment Data From Phase 2a Trial With ACH-1625 Based Regimen in Hepatitis C

Editor's pick
Achillion (press release)
23 April 2012
New & experimental hepatitis C treatment

J&J Open to Expanding Hepatitis C Collaboration With Vertex

Editor's pick
HCV New Drugs Research
20 April 2012
New & experimental hepatitis C treatment

Pancreatitis Forces Halt to HCV Drug Trial

Editor's pick
MedPage Today
20 April 2012
New & experimental hepatitis C treatment

Janssen Creates new Division to Launch TMC435 and Help Conquer Hepatitis C in EMEA

Editor's pick
Janssen press release
20 April 2012
New & experimental hepatitis C treatment

No Relevant Interactions Between Telaprevir and Two Newest Nonnucleosides Rilpivirine & Etravirine

Editor's pick
NATAP
20 April 2012
New & experimental hepatitis C treatment

Boehringer Ingelheim Hepatitis C Drugs Cured 82% in Trial

Editor's pick
Bloomberg
20 April 2012